Market revenue in 2023 | USD 398.1 million |
Market revenue in 2030 | USD 533.0 million |
Growth rate | 4.3% (CAGR from 2023 to 2030) |
Largest segment | Small molecule api |
Fastest growing segment | Small Molecule API |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Small Molecule API, Small Molecule Drug Product |
Key market players worldwide | Wuxi AppTec Co Ltd, EQT Corp, Thermo Fisher Scientific Inc, Lonza Group Ltd, Catalent Inc, Siegfried Holding AG, Boehringer Ingelheim, Labcorp Holdings Inc, Piramal Pharma Solutions, CordenPharma, Cambrex |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to small molecule innovator cdmo market will help companies and investors design strategic landscapes.
Small molecule api was the largest segment with a revenue share of 61.67% in 2023. Horizon Databook has segmented the Argentina small molecule innovator cdmo market based on small molecule api, small molecule drug product covering the revenue growth of each sub-segment from 2018 to 2030.
Argentina accounted for a market share of 12.15% in the Latin America small molecule innovator CDMO market in 2023. With regard to legislation, Argentina is among the most developed nations in Latin America.
Due to its favorable regulatory guidelines, cost compliance, and established clinical & manufacturing infrastructure, it is anticipated to be a lucrative market for small molecule innovator CDMOs. Moreover, the nation has synchronized its clinical R&D regulations with global norms and specifications.
To take advantage of Argentina's cost-effectiveness, time-saving, specialized knowledge, and compliance with international standards like GCP & GMP, several biotechnology and pharmaceutical companies may start outsourcing CDMO activities to the country over the next 10 years.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina small molecule innovator cdmo market , including forecasts for subscribers. This country databook contains high-level insights into Argentina small molecule innovator cdmo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account